KMDA
Kamada Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$8.85
+2.08%Forward multiples
Based on analyst estimates
- P/E forward
- 17.79x
- P/E 2026E
- 18.14x
- P/E 2027E
- 14.82x
- P/E 2028E
- 13.01x
- P/S forward
- 2.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- 23.11x
- PEG TTM
- 0.77x
- Price / book
- 1.89x
- Price / sales
- 2.66x
- Price / cash flow
- 14.18x
Enterprise value
- Enterprise value
- $452.4M
- EV / sales
- 2.36x
- EV / EBITDA
- 10.78x
- EV / EBIT
- 16.26x
- Market cap
- $510.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026